BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11487720)

  • 21. [Paclitaxel + carboplatin (TC)-resistant stage Ic squamous cell carcinomas arising in mature cystic teratomas of the ovary].
    Ishikawa M; Nakayama K; Yeasmin S; Katagiri A; Iida K; Nakayama N; Miyazaki K
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):747-52. PubMed ID: 20414041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant paclitaxel and cisplatin in uterine cervical cancer: long-term results.
    Park DC; Suh MJ; Yeo SG
    Int J Gynecol Cancer; 2009 Jul; 19(5):943-7. PubMed ID: 19574789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phase I clinical trial of weekly paclitaxel, weekly carboplatin, and concurrent radiotherapy for primary cervical cancer.
    Rao GG; Rogers P; Drake RD; Nguyen P; Coleman RL
    Gynecol Oncol; 2005 Jan; 96(1):168-72. PubMed ID: 15589596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective analysis of cisplatin/carboplatin plus paclitaxel in advanced or recurrent cervical cancer.
    Song D; Kong W; Zhang T; Han C; Liu T; Jiao S; Chen J
    J Obstet Gynaecol; 2019 Apr; 39(3):389-394. PubMed ID: 30663464
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prolonged remission of recurrent cervical carcinoma following paclitaxel and carboplatin chemotherapy with paclitaxel maintenance chemotherapy.
    Micha JP; Sassoon AF; Wong H; Goldstein BH
    Anticancer Drugs; 2015 Aug; 26(7):793-6. PubMed ID: 25933247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy with weekly carboplatin and paclitaxel for locally advanced cervical carcinoma.
    Mori T; Hosokawa K; Kinoshita Y; Watanabe A; Honjo H
    Int J Gynecol Cancer; 2008; 18(1):85-9. PubMed ID: 17587314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy followed by large cone resection as fertility-sparing therapy in stage IB cervical cancer.
    Salihi R; Leunen K; Van Limbergen E; Moerman P; Neven P; Vergote I
    Gynecol Oncol; 2015 Dec; 139(3):447-51. PubMed ID: 26050921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Weekly cisplatin therapy compared with triweekly combination chemotherapy as concurrent adjuvant chemoradiation therapy after radical hysterectomy for cervical cancer.
    Lee HN; Lee KH; Lee DW; Lee YS; Park EK; Park JS
    Int J Gynecol Cancer; 2011 Jan; 21(1):128-36. PubMed ID: 21330837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carboplatin and paclitaxel for advanced and recurrent cervical carcinoma: the British Columbia Cancer Agency experience.
    Tinker AV; Bhagat K; Swenerton KD; Hoskins PJ
    Gynecol Oncol; 2005 Jul; 98(1):54-8. PubMed ID: 15904950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radical surgery after neoadjuvant intra-arterial chemotherapy in stage IIIb squamous cell carcinoma of the cervix.
    Sugiyama T; Nishida T; Muraoka Y; Tokuda T; Kuromatsu H; Fujiyoshi K; Yakushiji M; Edamitu O; Haynbuchi N
    Int Surg; 1999; 84(1):67-73. PubMed ID: 10421022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A phase I study of concurrent weekly carboplatin and paclitaxel combined with intensity-modulated pelvic radiotherapy as an adjuvant treatment for early-stage cervical cancer patients with positive pelvic lymph nodes.
    Mabuchi S; Takahashi R; Isohashi F; Yokoi T; Ito K; Tsutui T; Ogata T; Yoshioka Y; Ogawa K; Kimura T
    Int J Gynecol Cancer; 2013 Sep; 23(7):1279-86. PubMed ID: 23835505
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of cisplatin/paclitaxel and carboplatin/paclitaxel in stage IVB, recurrent or persistent cervical cancer.
    Moore KN; Herzog TJ; Lewin S; Giuntoli RL; Armstrong DK; Rocconi RP; Spannuth WA; Gold MA
    Gynecol Oncol; 2007 May; 105(2):299-303. PubMed ID: 17303230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Primary clear cell carcinoma of the cervix: report of five cases and review of the literature].
    Tan YT; Zhang X; Lin ZQ; Chen Q; Wang LJ; Zhang BZ
    Zhonghua Fu Chan Ke Za Zhi; 2008 Feb; 43(2):120-3. PubMed ID: 18683751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of adjuvant chemotherapy with paclitaxel and nedaplatin for uterine cervical cancer with lymph node metastasis.
    Takekuma M; Shimokawa M; Nishio S; Omi H; Tabata T; Takei Y; Nasu K; Takahashi Y; Toyota S; Ichikawa Y; Arakawa A; Ito F; Tsubamoto H; Mori T; Hirashima Y; Ito K
    Cancer Sci; 2018 May; 109(5):1602-1608. PubMed ID: 29575254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic factors from a randomized phase III trial of paclitaxel and carboplatin versus paclitaxel and cisplatin in metastatic or recurrent cervical cancer: Japan Clinical Oncology Group (JCOG) trial: JCOG0505-S1.
    Nishio S; Kitagawa R; Shibata T; Yoshikawa H; Konishi I; Ushijima K; Kamura T
    Cancer Chemother Pharmacol; 2016 Oct; 78(4):785-90. PubMed ID: 27553435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Paclitaxel Plus Carboplatin Versus Paclitaxel Plus Cisplatin in Metastatic or Recurrent Cervical Cancer: The Open-Label Randomized Phase III Trial JCOG0505.
    Kitagawa R; Katsumata N; Shibata T; Kamura T; Kasamatsu T; Nakanishi T; Nishimura S; Ushijima K; Takano M; Satoh T; Yoshikawa H
    J Clin Oncol; 2015 Jul; 33(19):2129-35. PubMed ID: 25732161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of paclitaxel and carboplatin as a regimen for postoperative concurrent chemoradiotherapy of high risk uterine cervix cancer.
    Kim K; Chie EK; Wu HG; Ha SW; Kim JS; Kim IA; Lee HP
    Gynecol Oncol; 2006 Jun; 101(3):398-402. PubMed ID: 16330087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival Outcomes of Advanced and Recurrent Cervical Cancer Patients Treated with Chemotherapy: Experience of Northern Tertiary Care Hospital in Thailand.
    Boupaijit K; Suprasert P
    Asian Pac J Cancer Prev; 2016; 17(3):1123-7. PubMed ID: 27039736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervix.
    Tebbutt N; Rischin D; Quinn M; Rome R; Millward MJ; Toner GC; Bishop JF
    Aust N Z J Obstet Gynaecol; 1998 Feb; 38(1):87-90. PubMed ID: 9521400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenosquamous carcinoma of the uterine cervix--adjuvant chemotherapeutic treatment with paclitaxel and carboplatin; a case report.
    Radić V; Kukura V; Ciglar S
    Eur J Gynaecol Oncol; 2005; 26(4):449-50. PubMed ID: 16122201
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.